Natera and TransCode Therapeutics to Collaborate on Phase 2a Trial of TTX-MC138 in Colorectal Cancer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: NTRA) | Delayed: 391.86 -21.52 (5.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $413.38 | 52 Week High | $13.80 | |||
| Open | $408.47 | 52 Week Low | $6.52 | |||
| Day High | $416.00 | P/E | N/A | |||
| Day Low | $390.78 | EPS | $0.00 | |||
| Volume | 646,955 | |||||
| (NASDAQ: RNAZ) | Delayed: 1.77 +0.11 (6.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.66 | 52 Week High | $ | |||
| Open | $1.62 | 52 Week Low | $ | |||
| Day High | $1.80 | P/E | N/A | |||
| Day Low | $1.62 | EPS | $ | |||
| Volume | 15,604 | |||||
